Elite AF IDE Trial (Elite AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT07287436
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT07287436
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07287436. Allocation not applicable; no masking; primary purpose prevention. Start 2026-09-18 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Elite AF IDE Trial (Elite AF)
- Condition
- Atrial Fibrillation (AF)
- Condition
- Stroke
- Intervention (Device)
- WATCHMAN Elite LAAC Device
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct07287436- Content hash
f0be28d11348080d10dbcf3b22f3a1b0659c5fd42e99def733e499b3ebb081f1